Involvement of interleukin-6 in the biology and metastatic activity of B16F10 melanoma cells

European Cytokine Network

Volumn 9, Issue 2, 1998, Pages 187-192

  De Galdeano, Alicia García ^a   Boyano, Dolores ^a   Smith Zubiaga, Isabel ^a   Alvarez, Antonia ^a   Cantón, Irene ^a   Cañavate, Luz ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

B16f10 melanoma; IL 6; Metastasis

Indexed keywords

BETA1 INTEGRIN; HERMES ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; MELANOMA B16; METASTASIS; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL ADHESION MOLECULES; CELL DIVISION; INTERLEUKIN-6; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; RECEPTORS, INTERLEUKIN-2; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

ANIMALIA; MURINAE;

EID: 7144254470     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Rodeck U. 1993. Growth factor independence and growth regulatory pathways in human melanoma development. (Review) Cancer Metast. Rev. 12: 219.
2. Hirano T, Kishimoto T. 1992. Molecular biology and immunology of inlerleukin-6. Res. Immunol. 143: 723.
3. Sun W H, Kreisle R A, Phillips A W, Ershler W B. 1992. In vivo and in vitro characteristics of interleukin-6-translected B16 melanoma cells. Cancer Res. 52: 5412.
4. Katz A, Shulman L M, Porgador A, Revel M, Feldman M, Eisenbach L. 1993. Abrogation of B16 melanoma metastases by long-term low-dose interleukin-6 Therapy. J. Immunothr. 13: 98.
5. Cao X, Zhang W, Gu S, Yu Y, Tao Q, Ye T. 1995. Induction of antitumor immunity and treatment of preestablished tumor by interleukin-6-gene-transfected melanoma cells combined with low-dose interleukin-2. J. Cancer Res. Clin. Oncol. 121: 721.
6. Lu C, Kerbel R S. 1993. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J. Cell Biol. 120: 1281.
7. Taniguchi T, Minami Y. 1993. The IL-2/IL-2 receptor system: a current overview. (Review) Cell 73: 5.
8. Plaisance S, Rubinstein E, Alileche A, Han D S, Sahraoui Y, Mingari M C, Bellomo R, Rimoldi D, Colombo M P, Jasmin C, Carrel S, Azzarone B. 1993. Human melanoma cells express a functional interleukin-2 receptor. Int. J. Cancer 55: 164.
9. Alileche A, Plaisance S, Han D S, Rubinstein E, Mingari C, Bellomo R, Jasmin C, Azzarone B. 1993. Human melanoma cell line M14 secretes a functional interleukin-2. Oncogene 8: 1791.
10. Garća de Galdeano A, Boyano M D, Smith-Zubiaga I, Canavate M L. 1996. B16F10 murine melanoma cells express interleukin-2 and a functional interleukin-2 receptor. Tumor Biol. 17: 155.
11. Boyano M D, García de Galdeano A, Smith-Zubiaga I, Cañavate M L. 1997. IL-2 treatment of B16F10 melanoma cells stimulates melastatic colonization in the liver. Anticancer Res. 17: 1135.
12. Musso T, Espinoza-Delgado I, Pulkki K, Gusella G L, Longo D L, Varesio L. 1992. IL-2 induces IL-6 production in human monocytes. J. Immunol. 148: 795.
13. Shaw J, Meerovitch K, Bleackley R C, Paetkau V. 1988. Mechanisms regulating the level of IL-2 mRNA in T lymphocytes. J. Immunol. 140: 2243.
14. Plaetinck G, Combe M C, Corthesy P, Sperisen P, Kanamori H, Honjo T, Nabholz M. 1990. Control of IL-2 receptor-α expression by IL-1, tumor necrosis factor, and IL-2. Complex regulation via elements in the 5' flanking region. J. Immunol. 145: 3340.
15. Tamm I, Cardinale I, Kikuchi T, Krueger J G. 1994. E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells. Proc. Natl. Acad. Sci. USA 9: 4338.
16. Birch M, Mitchell S, Hart I R. 1991. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res. 51: 6660.
17. Taichman D B, Cybulsky M I, Diaffar I, Longenecker B M, Teixido J, Rice G E, Aruffo A, Bevilacqua M P. 1991. Tumor cell surface α4β1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1. Cell Regul. 2: 347.
18. Han D, Pottin-Clemenceau C, Imro M A, Scudeletti M, Doucet C, Puppo F, Brouty-Boye D, Vedrenne J, Sahraoui Y, Brailly H, Poggi A, Jasmin C, Azzarone B, Indiveri F. 1996. IL-2 triggers a tumor progression process in a melanoma cell line MELP, derived from a patient whose metastasis increased in size during IL-2/INF-α biotherapy. Oncogene 12: 1015.
19. Okahara H, Yagita H, Miyake K, Okumura K. 1994. Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis. Cancer Res. 54: 3233.
20. Garofalo A, Chririvi R G, Foglieni C, Pigott R, Mortarini R, Martin-Padura I, Anichini A, Gearing A J, Sanchez-Madrid F, Dejana E, Giavazzi R. 1995. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. Cancer Res. 55: 414.
21. Sironi M, Breviario F, Proserpio P, Biondi A, Vecchi A, Van Damme J, Dejana E, Mantovani A. 1989. IL-1 stimulates IL-6 production in endothelial cells. J. Immunol. 142: 549.
22. Morris J G, Tang L P, Sparacio S M, Benveniste E N. 1994. Signal transduction pathways mediating astrocyte IL-6 induction by IL-1β and tumor necrosis factor-α. J. Immunol. 152: 841.
23. Francis G M, Krohn E G, Woods K V, Buzaid A C, Grimm E A. 1996. Interleukin-6 production and secretion in human melanoma cell lines: regulation by interleukin-1. Melanoma Res. 6: 191.
24. Yang J, Hagan M K, Offermann M K. 1994. Induction of IL-6 gene expression in Kaposi's sarcoma cells. J. Immunol. 152: 943.
25. Castelli C, Sensi M, Lupetti R, Mortarini R, Panceri P, Anichini A, Parmiani G. 1994. Expression of interleukin-1α, interleukin-6. and tumor necrosis factor-α genes in human melanoma clones is associated with that of mutated N-RAS oncogene. Cancer Res. 54: 4785.
26. Lupetti R, Mortarini R, Panceri P, Sensi M, Anichini A. 1996. Interaction with fibronectin regulates cytokine gene expression in human melanoma cells. Int. J. Cancer 66: 110.
27. Ahmed A A, Nordlind K, Hedblad M, Lagerholm B, Schultzberg M, Lidén S. 1995. Interleukin (IL)-1α-and -IL-1β, IL-6, and tumor necrosis factor-α-like immunoreactivities in human common and dysplastic nevocellular nevi and malignant melanoma. Am. J. Dermatopathol. 17: 222.
28. Ciotti P, Rainero M L, Nicolò G, Spina B, Garrè C, Casabona F, Santi P L, Bianchi-Scarrà G. 1995. Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh bioptic specimens. Melanoma Res. 5: 41. 1.